We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$301B
AUM Growth
+$5.54B
Cap. Flow
-$7B
Cap. Flow %
-2.32%
Top 10 Hldgs %
14.22%
Holding
9,997
New
1,505
Increased
3,920
Reduced
3,391
Closed
881

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$937M
2
UBS icon
UBS Group
UBS
+$511M
3
MSFT icon
Microsoft
MSFT
+$402M
4
BIDU icon
Baidu
BIDU
+$338M
5
AAPL icon
Apple
AAPL
+$331M

Sector Composition

Rank Sector Weight
1 Technology 11.08%
2 Consumer Discretionary 6.75%
3 Financials 6.3%
4 Healthcare 5.83%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCRCU
7051
DELISTED
Decarbonization Plus Acquisition Corporation III Unit
DCRCU
$29K ﹤0.01%
+2,907
New +$28.9K
SMTX
7052
DELISTED
SMTC Corporation
SMTX
$29K ﹤0.01%
4,837
+3,140
+185% +$18.5K
CTIC
7053
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$29K ﹤0.01%
9,971
+5,693
+133% +$18.6K
BZQ icon
7054
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.46M
$28K ﹤0.01%
+183
New +$27.5K
CAMT icon
7055
Camtek
CAMT
$6.98B
$28K ﹤0.01%
947
-24,870
-96% -$667K
CBAN icon
7056
Colony Bankcorp
CBAN
$468M
$28K ﹤0.01%
1,813
-506
-22% -$7.4K
FHTX icon
7057
Foghorn Therapeutics
FHTX
$327M
$28K ﹤0.01%
2,136
-112
-5% -$1.83K
GHYG icon
7058
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
$28K ﹤0.01%
547
-776
-59% -$39.2K
GSIT icon
7059
GSI Technology
GSIT
$254M
$28K ﹤0.01%
4,187
-2,173
-34% -$16.3K
LAKE icon
7060
Lakeland Industries
LAKE
$117M
$28K ﹤0.01%
1,016
-1,376
-58% -$42.7K
PLTM icon
7061
GraniteShares Platinum Shares
PLTM
$188M
$28K ﹤0.01%
2,414
+1,555
+181% +$17.8K
ROMO icon
7062
Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO
$25.7M
$28K ﹤0.01%
1,061
-968
-48% -$25.1K
TXMD icon
7063
TherapeuticsMD
TXMD
$24.2M
$28K ﹤0.01%
411
-215
-34% -$16.8K
EGF
7064
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$28K ﹤0.01%
2,182
+1,152
+112% +$15K
NRGD
7065
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
$28K ﹤0.01%
+3
New +$45.4K
PCTI
7066
DELISTED
PCTEL, Inc. Common Stock
PCTI
$28K ﹤0.01%
4,031
+773
+24% +$5.92K
GLCN
7067
DELISTED
VanEck China Growth Leaders ETF
GLCN
$28K ﹤0.01%
630
-1,257
-67% -$61.6K
APTX
7068
DELISTED
Aptinyx Inc. Common Stock
APTX
$28K ﹤0.01%
9,180
+83
+0.9% +$298
AGRX
7069
DELISTED
Agile Therapeutics
AGRX
$28K ﹤0.01%
7
AGFS
7070
DELISTED
AgroFresh Solutions Inc
AGFS
$28K ﹤0.01%
13,988
+5,860
+72% +$13.1K
FOXW
7071
DELISTED
FoxWayne Enterprises Acquisition Corp. Class A Common Stock
FOXW
$28K ﹤0.01%
+2,792
New +$27.6K
ETPA
7072
DELISTED
Ecofin Digital Payments Infrastructure Fund
ETPA
$28K ﹤0.01%
636
+629
+8,986% +$28.4K
LOGC
7073
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$28K ﹤0.01%
3,841
+766
+25% +$6.3K
PHAS
7074
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$28K ﹤0.01%
8,150
+6,842
+523% +$27.8K
PZN
7075
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$28K ﹤0.01%
2,691
+575
+27% +$5.41K

Similar funds

UBS Group's Q1 2021 Portfolio in Review

As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,391 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

  • UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
  • UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
  • UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
  • UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
  • UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
  • UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
  • UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.